Aegte — Aegte Lifescience Private Limited
Aegte Lifescience Private Limited is a Private Non-govt company company incorporated in 2021 and based in Delhi, India. It was founded by Rupali. Aegte Lifescience Private Limited operates in Non-metallic Minerals (NIC 26990) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2021-22, the company reported revenue of ₹0 and a net loss of ₹10.0K. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Aegte - Internet first brand offering beauty products.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +10d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +22d | filed |
| MGT-7 | FY2023-24 | 23 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 25 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Aegte Lifescience Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 123646965 | Kotak Mahindra Bank Ltd(Bank) | ₹18.20 Cr | 04 Jul 2021 | Open |
| 193528314 | State Bank of India(Bank) | ₹9.59 Cr | 12 Mar 2023 | Open |
| 240601803 | HDFC Bank Ltd(Bank) | ₹90.12 L | 12 Mar 2020 | Open |
| 499574839 | ICICI Bank Ltd(Bank) | ₹84.34 L | 04 Jul 2022 | Open |
| 723707635 | HDFC Bank Ltd(Bank) | ₹13.78 Cr | 19 Sep 2021 | Satisfied |
Charge IDs, lenders & amounts for Aegte Lifescience Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2021-22 | — |
Detailed Financials
1 FYs| Line item | 2021-22 |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹21.51 Cr | +5.8% | +15.8% | +18.7% |
| Profit after Tax | ₹-1.12 Cr | -1.1% | +4.6% | +10.1% |
| Net Worth | ₹10.46 Cr | +9.5% | +13.9% | +6.0% |
| Employees | 138 | +17.3% | +20.4% | +7.2% |
Audited financials & ratios for Aegte Lifescience Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2021-22 | — | — | -11.11% | -10.00% | 1.11 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 4 | 15,26,909 | 68.30% |
| Institutional Investors | 3 | 1,29,710 | 5.80% |
| Public & Others | 44 | 5,79,061 | 25.90% |
Promoter, institutional & public holding for Aegte Lifescience Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
6 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.